June 11, 2015 - Patients who received a bare metal coronary stent did not display significant differences in rates of ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
June 11, 2015
June 9, 2015 - AstraZeneca announced full results from the PEGASUS-TIMI 54 study, a large-scale outcomes trial ...
June 10, 2015June 4, 2015 - Researchers from the University of Chicago and Stanford University combed through scientific literature ...
June 04, 2015
May 21, 2015 — Janssen Pharmaceuticals Inc. and its development partner Bayer HealthCare announced results from the ...
May 21, 2015
May 18, 2015 — A risk assessment algorithm combining clinical risk factors and platelet function test results may help ...
May 18, 2015
May 18, 2015 — Patients with a high-risk paclitaxel drug-eluting stent given the shorter-acting antiplatelet drug cilost ...
May 18, 2015
May 15, 2015 — Prasugrel (Effient) is more likely to be given to lower-risk heart disease patients undergoing percutaneo ...
May 15, 2015May 14, 2015 — A new study reports that antiplatelet drug ticagrelor (Brilinta) works faster and is more effective in bl ...
May 14, 2015
May 14, 2015 — Combining statins for low-density lipoprotein (LDL) and calcium channel antagonists for blood pressure re ...
May 14, 2015
May 6, 2015 — People with acute coronary syndrome (ACS) who undergo an angioplasty procedure and receive a heart stent ...
May 06, 2015One life-threatening complication of lung cancer surgery is the formation of blood clots in the lungs (also called ...
May 01, 2015
April 30, 2015 — AstraZeneca announced that the U.S. Food and Drug Administration (FDA) has accepted a supplemental new ...
April 30, 2015
April 29, 2015 — The Medicines Company announced that the U.S. Food and Drug Administration (FDA) Cardiovascular and ...
April 29, 2015
April 16, 2015 — The U.S. Food and Drug Administration (FDA) approved Amgen’s ivabradine (Corlanor) to reduce ...
April 16, 2015April 9, 2015 — A study including more than 20,000 adults in China found combined use of the hypertension medication ...
April 09, 2015© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now